Zofenopril

This classification denotes an ace inhibitor with the molecular formula C22H23NO4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 290ZY759PI chemically known as r-proline, 1-(3-(benzoylthio)-2-methyl-1-oxopropyl)-4-(phenylthio)-, (1(r*),2.alpha.,4.alpha.)- but generally known as zofenopril, which bears US NIH Compound Identifier 92400. European Medicines Agency schedules Zofenopril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00170MIG. The term ZOFENOPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24. ). Most nations schedule zofenopril under HS 29339990 and SITC 51577. As of Q4 2014, ZOFENOPRIL remains the US FDA Preferred Term for this commodity. Zofenopril bears US NLM identifiers UMLS ID C0078836 and NCI Concept Code C82219. SMILES: CC(CSC(=O)C1=CC=CC=C1)C(=O)N2CC(CC2C(=O)O)SC3=CC=CC=C3.